HomeNews Room

News Room

Media Contacts

1413 K Street NW, 4th Floor
Washington, D.C. 20005
Telephone: (202) 682-2640
Fax: (202) 682-2648

General Inquiries – nwhn@nwhn.org
Media Inquiries – media@nwhn.org

 

  • The National Women’s Health Network Responds to Announcement that the Senate Won’t Vote on Trumpcare This Week
    June 27, 2017
    For Immediate Release Contact: Sarah Christopherson, schristopherson@nwhn.org Telephone: (202) 796-3065 The National Women’s Health Network Responds to Announcement that the Senate Won’t Vote on Trumpcare This Week Washington, D.C. – In response to widespread public outrage, Senate Republicans announced today that they were postponing a planned vote on their bill (also known as “Trumpcare”) to repeal parts of the ...
  • The NWHN Responds to Confirmation of Scott Gottlieb to Head the FDA
    May 10, 2017
    For Immediate Release Shaniqua Seth Email: sseth@nwhn.org Telephone: (301) 965-0097   The NWHN Responds to Confirmation of Scott Gottlieb to Head the FDA: His Views are Harmful to Women’s Health   Washington, D.C. – On Tuesday, the Senate voted to confirm conservative physician and former Bush official Scott Gottlieb to head the U.S. Food and Drug Administration (FDA) in a 57-42 vote. The ...
  • NWHN is Outraged — House Votes to Take Away Health Care!
    May 4, 2017
    FOR IMMEDIATE RELEASE May 4, 2017 Contact: Shaniqua Seth at sseth@nwhn.org or (301) 965-0097   Washington, DC – Today, the House of Representatives voted 217 – 213 to repeal the Affordable Care Act (ACA) and pass Trump’s American Health Care Act (AHCA). This harmful legislation was rushed to the House floor and voted on before the full implications of ...
  • The National Women’s Health Network Opposes Gottlieb’s Nomination as FDA Commissioner
    March 13, 2017
    FOR IMMEDIATE RELEASE: March 13, 2017 Contact: Shaniqua Seth at sseth@nwhn.org or 202.682-2640, ext. 225 Washington, D.C. – On Friday, the White House announced the nomination of conservative physician and former Bush official Scott Gottlieb as commissioner of the Food and Drug Administration (FDA). The National Women’s Health Network has strong concerns that if Dr. Gottlieb is ...
  • The National Women’s Health Network Opposes Nomination of Judge Neil Gorsuch to the U.S. Supreme Court
    February 1, 2017
    FOR IMMEDIATE RELEASE Contact: Shaniqua Seth at sseth@nwhn.org or 202.682-2640, ext. 225 Washington, D.C. – For ten months, Senate Republicans have blocked consideration of Judge Merrick Garland, President Obama’s centrist pick, preferring to keep the seat vacant. Having set that precedent, the Senate should now take the time necessary to carefully vet far-right Judge Neil Gorsuch and ...
  • FDA Takes Steps to Protect Women’s & Consumer Health over Industry Profits
    January 23, 2017
    For Immediate Release Contact: Shaniqua Seth at sseth@nwhn.org or 202.682-2640, ext. 225 WASHINGTON, DC — Last week, the U.S. Food and Drug Administration released a 63-page memo regarding the dissemination of information about off-label use of medical products. The memo explains that drug makers need to provide evidence of the safety and effectiveness of the medical products ...
  • Health Advocates Issue One-Year Report Card on Addyi, the Female Libido Drug
    August 18, 2016
    FOR IMMEDIATE RELEASE Contact: Shaniqua Seth at sseth@nwhn.org or 202.682-2640, ext. 225 WASHINGTON, DC – August 18th marks the one-year anniversary of the Food and Drug Administration’s (FDA) approval of flibanserin (brand name: Addyi), the so-called “female Viagra” pill. In light of recent developments, the National Women’s Health Network (NWHN) has issued a one-year report card. The report ...
  • NWHN Applauds FDA for New Evidence Based Label Demonstrating Continued Safety & Efficacy of Medication Abortion
    April 4, 2016
    FOR IMMEDIATE RELEASE Contact: Shaniqua Seth at sseth@nwhn.org or 202.682-2640, ext. 225 WASHINGTON, DC — This week, the U.S. Food and Drug Administration (FDA) approved an updated, evidence-based label for mifepristone (Mifeprex®), a drug used to end an early pregnancy. The National Women’s Health Network commends the FDA for putting women’s health over politics and making this ...
  • “FDA’s Actions on Essure are Steps in the Right Direction” NWHN statement in response to FDA Draft Guidance
    February 29, 2016
    FOR IMMEDIATE RELEASE Contact: Cindy Pearson at cpearson@nwhn.org or 202.682.2640, ext. 0 Safe & effective contraception, including permanent contraception, is an essential component of women’s health and economic security.  Women rely on the FDA to make sure that the risks of contraceptive methods are low, and well understood.  Today, the FDA took important first steps to improve women’s ...
  • National Women’s Health Network Urges Women to Resist “Cheap” Gimmicks for Losing Weight in the New Year
    January 7, 2016
    FOR IMMEDIATE RELEASE Contact: Christina Cherel at ccherel@nwhn.org or 202.682.2640, ext 224 With the New Year often comes resolutions to lead happier – and healthier – lives. The National Women’s Health Network (“NWHN”) encourages women who have made New Year’s resolutions to lose weight to resist misleading claims about “diet drugs” and cheap gimmicks from drug companies ...